127109-66-4

Basic information

• Product Name: 3-iodophenylacetic acid chloride
• Synonyms: 3-iodophenylacetic acid chloride
• CAS NO: 127109-66-4
• Molecular Weight: 280.493
• Mol File: 127109-66-4.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 3-iodophenylacetic acid chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 3-iodophenylacetic acid chloride(127109-66-4)
• EPA Substance Registry System: 3-iodophenylacetic acid chloride(127109-66-4)

Safety Data

• Hazardous Substances Data: 127109-66-4(Hazardous Substances Data)

Upstream product

• 1878-69-9 3-iodophenylacetic acid 

Downstream Products

• 947243-86-9 C₂₀H₃₆O₂C₆H₆OCOC₆H₃ICH₂ 
• 1174182-24-1 C₁₆H₁₈IN₅ 
• 1174182-28-5 C₁₅H₁₇IN₄ 
• 1174182-27-4 C₁₂H₉IN₂O 
• 1391108-25-0 1-(4-chlorophenyl)-2-(3-iodophenyl)ethanone 
• 1391106-79-8 C₄₆H₄₇Cl₂N₇O₆S₂ 
• 1391106-95-8 C₄₃H₄₄ClN₇O₅S₂ 
• 1391106-87-8 C₄₄H₄₇ClN₈O₄S₂ 
• 1391106-88-9 C₄₄H₄₇ClN₈O₄S₂ 
• 1428146-09-1 5-(4-chlorophenyl)-4-(3-(4-(4-nitrophenyl)piperazin-1-yl)-phenyl)isoxazole 
• 1428146-08-0 ethyl 2-chloro-5-(4-chlorophenyl)-1-methyl-4-(3-(4-(4-nitrophenyl)piperazin-1-yl)phenyl)-1H-pyrrole-3-carboxylate 
• 1428146-00-2 ethyl 2-chloro-5-(4-chlorophenyl)-4-(3-iodophenyl)-1-methyl-1H-pyrrole-3-carboxylate 
• 1428145-99-6 ethyl 2-chloro-5-(4-chlorophenyl)-4-(3-iodophenyl)-1H-pyrrole-3-carboxylate 
• 1391108-37-4 ethyl 4-(4-chlorophenyl)-2-cyano-3-(3-iodophenyl)-4-oxobutanoate 

Relevant articles and documents

FUSED [1,2,4]THIADIAZINE DERIVATIVES WHICH ACT AS KAT INHIBITORS OF THE MYST FAMILY

A compound of formula (I): which inhibits the activity of one or more KATs of the MYST family, i.e., TIP60, KAT6B, MOZ, HBO1 and MOF.

Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by toxoplasma gondii

Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1). Here we synthesized a number of new derivatives of 3-methyl-benzyl-PP (3-MB-PP, or 1). The potency of PP analogues in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC 50 values) were highly correlated and occurred in a CDPK1-specific manner. Chemical modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compounds with enhanced stability while retaining activity. Several of these more potent compounds were able to prevent lethal infection with T. gondii in the mouse model. Collectively, the strategies outlined here provide a route for development of more effective compounds for treatment of toxoplasmosis and perhaps related parasitic diseases.

Ring B functionalization of scalarane sesterterpenes by radical relay halogenation

The functionalization of the B-ring of the scalarane framework has been achieved for the first time by a radical relay halogenation (RRH) synthetic method. The known scalaranic methyl ester, which was prepared by a procedure with an overall yield higher than those reported in the literature, has been used as the starting substrate. Some theoretical considerations explaining the course of RRH reaction are also presented.